Back to results
US 8,569,298 B2Granted
Pyridine compounds
AssigneeAstraZeneca AB
InventorsBernard Christophe Barlaam, Patrick Ple, Kevin Michael Foote, Clifford David Jones
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds that inhibit of focal adhesion kinase function, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment in warm-blooded animals such as humans of diseases such as cancer.
Claims17
A compound of formula I:
- wherein:
- ring Q is selected from pyrazolyl and imidazolyl;
- R1 is selected from halo, trifluoromethyl, cyclopropyl, cyano, C1-4alkyl and C1-4alkoxy;
- n is 0, 1, 2 or 3;
- wherein the values of R2 may be the same or different;
- R2 is selected from halo, nitro, cyano, hydroxy, trifluoromethoxy, amino, carboxy, carbamoyl, mercapto, ureido, sulfonylamino, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C2-6alkenyloxy, C2-6alkynyloxy, C1-6alkanoyl, C1-6alkanoyloxy, N—(C1-6alkyl)amino, N,N—(C1-6alkyl)2-amino, N′—(C1-6alkyl)ureido, N′,N′—(C1-6alkyl)2ureido, N′—(C1-6alkyl)-N—(C1-6alkyl)ureido, N′,N′—(C1-6alkyl)2-N—(C1-6alkyl)ureido, C1-6alkanoylamino, N—(C1-6alkyl)-C1-6alkanoylamino, N—(C1-6alkyl)carbamoyl, N,N—(C1-6alkyl)2-carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkylsulfonylamino, N—(C1-6alkyl)aminosulfonyl, N,N—(C1-6alkyl)2-aminosulfonyl, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, N—(C1-6alkyl)C1-6alkoxycarbonylamino, C1-6alkylsulfonylaminocarbonyl, N—(C1-6alkyl)C1-6alkylsulfonylaminocarbonyl, carbocyclyl-X1—, heterocyclyl-X2— and heteroaryl-X3—;
- wherein R2 may be optionally substituted on carbon by one or more R7;
- and wherein if a heterocyclyl or heteroaryl within R2 contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from R8;
- and wherein any heterocyclyl within R2 optionally bears 1 or 2 oxo or thioxo substituents;
- or two adjacent R2 groups together with the carbon atoms to which they are attached form a carbocyclic, heteroaromatic or heterocyclic ring, which carbocyclic, heterocyclic or heteroaromatic ring may be optionally substituted on carbon by one or more R9;
- and wherein if said heterocyclic or heteroaromatic ring so formed contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from R10;
- and wherein a carbocyclic or heterocyclic so formed optionally bears 1 oxo substituent;
- R3 is selected from hydrogen, hydroxy, C1-4alkyl and C1-4alkoxy;
- and wherein R3 may be optionally substituted on carbon by one or more substituents selected from hydroxy, amino, C1-4alkoxy, N—(C1-4alkyl)amino and N,N—(C1-4alkyl)2-amino;
- R4 is selected from hydrogen and C1-4alkyl;
- and wherein R4 may be optionally substituted on carbon by one or more substituents selected from hydroxy, amino, C1-4-alkoxy, N—(C1-4alkyl)amino and N,N—(C1-4-alkyl)2-amino;
- or R3 and R4 together with the nitrogen atom to which they are attached form a 4 or 5 membered heterocyclyl ring, which heterocyclyl ring may be optionally substituted on carbon by one or more C1-4alkyl;
- or the —C(O)NR3R4 group together with the carbon atom to which it is attached and the R5c group together with the carbon atom to which it is attached (3-position of the phenyl ring) form a heterocyclic ring, which heterocyclic ring contains a —C(O)N(R3)— group as a ring member;
- wherein R3 is as hereinbefore defined, or the N(R3) ring member together with an adjacent ring member together form a heterocyclic ring;
- and wherein any heterocyclic ring so formed by the C(O)NR3R4 or NR3 ring member may be optionally substituted on carbon by one or more R3a selected from C1-4alkyl, C1-4alkoxy, halo, cyano, hydroxy and oxo;
- and wherein if said heterocyclyl ring contains an —NH— moiety that nitrogen may be optionally substituted by R3b selected from C1-4alkyl, C1-4alkanoyl, C1-4alkylsulfonyl, C1-4alkoxycarbonyl, carbamoyl, N—(C1-4alkyl)carbamoyl and N,N—(C1-4-alkyl)carbamoyl;
- R5 is selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulfamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N—(C1-6alkyl)amino, N,N—(C1-6alkyl)2-amino, C1-6 alkanoylamino, N—(C1-6alkyl)carbamoyl, N,N—(C1-6alkyl)2-carbamoyl, C1-6alkylS(O)b wherein b is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, N—(C1-6alkyl)sulfamoyl, N,N—(C1-6alkyl)2sulfamoyl, C1-6alkylsulfonylamino, carbocyclyl-X7—, heterocyclyl-X8— and heteroaryl-X9—;
- and wherein R5 may be optionally substituted on carbon by one or more groups selected from halo, nitro, cyano, hydroxy, amino, C1-4alkyl, C1-4alkoxy, N—(C1-4alkyl)amino, N,N—(C1-4alkyl)2-amino, carbocyclyl-X10—, heterocyclyl-X11— and heteroaryl-X12—;
- and wherein if a heterocyclyl or heteroaryl within R5 contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from C1-4alkyl, C1-4alkanoyl, C1-4alkylsulfonyl, C1-4alkoxycarbonyl, carbamoyl, N—(C1-4alkyl)carbamoyl, N,N—(C1-4alkyl)carbamoyl, benzyl, benzyloxycarbonyl, benzoyl and phenylsulfonyl;
- and wherein any heterocyclyl within R5 optionally bears 1 or 2 oxo or thioxo substituents;
- R5a is selected from hydrogen and halo;
- R5b and R5c are independently selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulfamoyl, C1-4alkyl, C2-4alkenyl, C2-4alkynyl, C1-4alkoxy, C1-4alkanoyl, C1-4alkanoyloxy, N—(C1-4alkyl)amino, N,N—(C1-4alkyl)2-amino, C1-4-alkanoylamino, N—(C1-4alkyl)carbamoyl, N,N—(C1-4alkyl)2-carbamoyl, C1-4alkylS(O)c wherein c is 0 to 2, C1-4alkoxycarbonyl, C1-4alkoxycarbonylamino, N—(C1-4alkyl)sulfamoyl, N,N—(C1-4alkyl)2sulfamoyl and C1-4alkylsulfonylamino;
- and wherein R5b and R5c may be independently optionally substituted on carbon by one or more groups selected from halo, nitro, cyano, hydroxy, amino, C1-4alkoxy, N—(C1-4alkyl)amino and N,N—(C1-4-alkyl)2-amino;
- R6 is selected from hydrogen and C1-4alkyl;
- R7 and R9 are independently selected from halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulfamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N—(C1-6alkyl)amino, N,N—(C1-6alkyl)2-amino, C1-6alkanoylamino, N—(C1-6alkyl)carbamoyl, N,N—(C1-6alkyl)2-carbamoyl, C1-6alkylS(O)d wherein d is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, N—(C1-6alkyl)sulfamoyl, N,N—(C1-6alkyl)2sulfamoyl, C1-6alkylsulfonylamino, carbocyclyl-X4—, heterocyclyl-X5— and heteroaryl-X6—;
- wherein R7 may be optionally substituted on carbon by one or more R11;
- and wherein if any heterocyclyl in R7 and R9 contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from R12;
- and wherein any heterocyclyl within R7 and R9 optionally bears 1 or 2 oxo or thioxo substituents;
- R8, R10 and R12 are independently selected from selected from C1-6alkyl, C1-6alkanoyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, carbamoyl, N—(C1-6alkyl)carbamoyl, N,N—(C1-6alkyl)carbamoyl, benzyl, benzyloxycarbonyl, benzoyl and phenylsulfonyl;
- wherein R8, R10 and R12 may be optionally substituted on carbon by one or more R13;
- and
- R11 and R13 are independently selected from halo, nitro, cyano, hydroxy, trifluoromethoxy, trifluoromethyl, amino, carboxy, carbamoyl, mercapto, sulfamoyl, methyl, ethyl, cyclopropyl, cyclobutyl, methoxy, ethoxy, acetyl, acetoxy, methylamino, ethylamino, dimethylamino, diethylamino, N-methyl-N-ethylamino, acetylamino, N-methylcarbamoyl, N-ethylcarbamoyl, N,N-dimethylcarbamoyl, N,N-diethylcarbamoyl, N-methyl-N-ethylcarbamoyl, methylthio, ethylthio, methylsulfinyl, ethylsulfinyl, mesyl, ethylsulfonyl, methoxycarbonyl, ethoxycarbonyl, N-methylsulfamoyl, N-ethylsulfamoyl, N,N-dimethylsulfamoyl, N,N-diethylsulfamoyl and N-methyl-N-ethylsulfamoyl;
- X1, X2 and X3 are independently selected from a direct bond, —O—, —N(R22)—, —S—, —C(O)—, —N(R14)C(O)—, —C(O)N(R14)—, —N(R16)CON(R17)—, —OC(R18)2—, —SC(R19)2— and —N(R20)C(R21)2—;
- X4, X5 and X6 are independently selected from a direct bond, —O—, —N(R22)—, —C(O)—, —N(R14)C(O)—, —C(O)N(R14)—, —S(O)e—, —SO2N(R15)—, —N(R15)SO2—, —N(R16)CON(R17)—, —OC(R18)2—, —SC(R19)2— and —N(R20)C(R21)2—;
- X7, X8 and X9 are independently selected from a direct bond, —O—, —N(R22)—, —S—, —C(O)—, —N(R14)C(O)—, —C(O)N(R14)—, —N(R16)CON(R17)—, —OC(R18)2—, —SC(R19)2— and —N(R20)C(R21)2—;
- X10, X11 and X12 are independently selected from a direct bond, —O—, —N(R22)—, —C(O)—, —N(R14)C(O)—, —C(O)N(R14)—, —S(O)e—, —SO2N(R15)—, —N(R15)SO2—, —N(R16)CON(R17)—, —OC(R18)2—, —SC(R19)2— and —N(R20)C(R21)2—;
- and
- R14, R15, R16, R17, R18, R19, R20, R21 and R22 are independently selected from hydrogen or C1-6alkyl and e is independently 0-2;
- or a pharmaceutically acceptable salt thereof.
41 more elements
Dependencies are inferred from the claim text.